82
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Elevated levels of the complement regulator protein CD59 in severe acute pancreatitis

, MD, , , , , , , & show all
Pages 350-355 | Received 14 Aug 2007, Published online: 08 Jul 2009

References

  • McKay CJ, Evans S, Sinclair M, Carter CR, Imrie CW. High early mortality rate from acute pancreatitis in Scotland, 1984–1995. Br J Surg 1999; 86: 1302–5
  • Appelros S, Borgstrom A. Incidence, aetiology and mortality rate of acute pancreatitis over 10 years in a defined urban population in Sweden. Br J Surg 1999; 86: 465–70
  • Baron TH, Morgan DE. Acute necrotizing pancreatitis. N Engl J Med 1999; 340: 1407–12
  • Bradley EL, III A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993; 128:586–90.
  • Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992; 216: 117–34
  • Vincent JL, Akca S, De Mendonca A, Haji-Michael P, Sprung C, Moreno R, et al. SOFA Working Group. Sequntial organ failure assessment. The epidemiology of acute respiratory failure in critically ill patients. Chest 2002; 121: 1602–9
  • Walport MJ. Complement. First of two parts. N Engl J Med 2001; 344: 1058–66
  • Jacob HS, Hammerschmidt DH. Tissue damage caused by activated complement and granulocytes in shock lung, post perfusion lung and after amniotic fluid embolism: ramifications for therapy. Ann Chir Gynaecol 1982; Suppl 196: 3–9
  • Roxvall LI, Bengtson LA, Heideman JM. Anaphylatoxins and terminal complement complexes in pancreatitis. Evidence of complement activation in plasma and ascites fluid of patients with acute pancreatitis. Arch Surg 1990; 125: 918–21
  • Roxvall L, Bengtson A, Heideman M. Anaphylatoxin generation in acute pancreatitis. J Surg Res 1989; 47: 138–43
  • Foulis AK, Murray WR, Galloway D, McCartney AC, Lang E, Veitch J, et al. Endotoxaemia and complement activation in acute pancreatitis in man. Gut 1982; 23: 656–61
  • Duchateau J, Haas M, Schreyen H, Radoux L, Sprangers I, Noel FX, et al. Complement activation in patient at risk of developing the adult respiratory distress syndrome. Am Rev Respir Dis 1984; 130: 1058–64
  • Whicher JT, Barnes MP, Brown A, Cooper MJ, Read R, Walters G, et al. Complement activation and complement control proteins in acute pancreatitis. Gut 1982; 23: 944–50
  • Acioli JM, Isobe M, Kawasaki S. Early complement system activation and neutrophil priming in acute pancreatitis: participation of trypsin. Surgery 1997; 122: 909–17
  • Morgan BP. Regulation of the complement membrane attack pathway. Crit Rev Immunol 1999; 19: 173–98
  • Wang W, Shang LH, Jacobs DO. Complement regulatory protein CD59 involves c-SRC related tyrosine phosphorylation of the creatine transporter in skeletal muscle during sepsis. Surgery 2002; 132: 334–40
  • Meri S, Lehto T, Sutton CW, Tyynela J, Baumann M. Structural composition and functional characterization of soluble CD59: heterogeneity of the oligosaccharide and glycophosphoinositol (GPI) anchor revealed by laser-desorption mass spectrometric analysis. Biochem J 1996; 316: 923–35
  • Lehto T, Honkanen E, Teppo AM, Meri S. Urinary excretion of protectin (CD59), complement C5b-9 and cytokines in membranous glomerulonephritis. Kidney Int 1995; 47: 1403–11
  • Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17: 857–72
  • Gloor B, Stahel PF, Muller CA, Schmidt OI, Buchler MW, Uhl W. Predictive value of complement activation fragments C3a and sC5b-9 for development of severe disease in patients with acute pancreatitis. Scand J Gastroenterol 2003; 38: 1078–82
  • Vakeva A, Laurila P, Meri S. Loss of expression of protectin (CD59) is associated with complement membrane attack complex deposition in myocardial infarction. Lab Invest 1992; 67: 608–16
  • Rautemaa R, Meri S. Protection of gingival epithelium against complement-mediated damage by strong expression of the membrane attack complex inhibitor protectin (CD59). J Dent Res 1996; 75: 568–74
  • Morgan BP. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. Biochem J 1989; 264: 1–14
  • Vakeva A, Lehto T, Takala A, Meri S. Detection of a soluble form of the complement membrane attack complex inhibitor CD59 in plasma after acute myocardial infarction. Scand J Immunol 2000; 52: 411–4

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.